IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-05979-8.html
   My bibliography  Save this article

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Author

Listed:
  • Lien Van Hoecke

    (VIB
    Ghent University)

  • Sandra Van Lint

    (VIB
    Ghent University)

  • Kenny Roose

    (VIB
    Ghent University)

  • Alexander Van Parys

    (VIB
    Ghent University)

  • Peter Vandenabeele

    (Ghent University
    VIB)

  • Johan Grooten

    (Ghent University)

  • Jan Tavernier

    (VIB
    Ghent University)

  • Stefaan Koker

    (Ghent University)

  • Xavier Saelens

    (VIB
    Ghent University)

Abstract

Cancer immunotherapy can induce durable antitumor responses. However, many patients poorly respond to such therapies. Here we describe a generic antitumor therapy that is based on the intratumor delivery of mRNA that codes for the necroptosis executioner mixed lineage kinase domain-like (MLKL) protein. This intervention stalls primary tumor growth and protects against distal and disseminated tumor formation in syngeneic mouse melanoma and colon carcinoma models. Moreover, MLKL-mRNA treatment combined with immune checkpoint blockade further improves the antitumor activity. MLKL-mRNA treatment rapidly induces T cell responses directed against tumor neo-antigens and requires CD4+ and CD8+ T cells to prevent tumor growth. Type I interferon signaling and Batf3-dependent dendritic cells are essential for this mRNA treatment to elicit tumor antigen-specific T cell responses. Moreover, MLKL-mRNA treatment blunts the growth of human lymphoma in mice with a reconstituted human adaptive immune system. MLKL-based treatment can thus be exploited as an effective antitumor immunotherapy.

Suggested Citation

  • Lien Van Hoecke & Sandra Van Lint & Kenny Roose & Alexander Van Parys & Peter Vandenabeele & Johan Grooten & Jan Tavernier & Stefaan Koker & Xavier Saelens, 2018. "Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes," Nature Communications, Nature, vol. 9(1), pages 1-17, December.
  • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05979-8
    DOI: 10.1038/s41467-018-05979-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-05979-8
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-018-05979-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Cheng-Yu Liao & Ge Li & Feng-Ping Kang & Cai-Feng Lin & Cheng-Ke Xie & Yong-Ding Wu & Jian-Fei Hu & Hong-Yi Lin & Shun-Cang Zhu & Xiao-Xiao Huang & Jian-Lin Lai & Li-Qun Chen & Yi Huang & Qiao-Wei Li , 2024. "Necroptosis enhances ‘don’t eat me’ signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis," Nature Communications, Nature, vol. 15(1), pages 1-23, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05979-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.